Urinary Tract Infection Testing Market to Exceed US$ 905.1 million by 2030, By Persistence Market Research
January 25, 2024 12:46 ET | Persistence Market Research
New York, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Urinary Tract Infection (UTI) Testing involves the analysis of urine samples to identify the presence of bacteria or other indicators of infection in the...
lifearc logo.png
LifeArc - New UK-India research project trialling easy-to-use test to help fight against global threat of antimicrobial resistance
November 30, 2023 02:00 ET | LifeArc
New UK-India research project trialling easy-to-use test to help fight against global threat of antimicrobial resistance The second round of the Diagnostics for One Health and User Driven Solutions...
TIP_link_300x300.jpg
Test Strip Market Growth Worth $12.5 Billion, Globally, by 2030 - Exclusive Report by The Insight Partners
October 25, 2023 05:40 ET | The Insight Partners
Pune, India, Oct. 25, 2023 (GLOBE NEWSWIRE) -- A test strip is crucial for the medical diagnostics industry, especially for blood sugar testing and urinalysis. Test strips consist of multiple...
Azure logo new flatter arc-1200.png
Azure Biotech Announces Educational Initiative to Create Awareness of Unmet Women’s Menopausal Medical Issue
August 30, 2023 12:55 ET | Azure Biotech
RIVER VALE, N.J., Aug. 30, 2023 (GLOBE NEWSWIRE) -- Azure Biotech, Inc., a privately held women’s health company that is developing novel formulations of lasofoxifene for vulvovaginal atrophy (VVA),...
Future Market Insights.png
Rising Global UTI Cases and Multidrug-Resistant Bacteria: Fueling the Urinary Tract Infection Testing Market to US$ 1.1 Billion by 2033 | Future Market Insights NEWARK, Del, Aug. 03, 2023 (GLOBE NEWSWIRE) -- The global Urinary Tract Infection Testing Market is expected to grow significantly in the coming years, driven by several factors. These include...
OpGen.jpg
OpGen Presents Unyvero Urinary Tract Infection Panel Trial Results at ASM Microbe 2023 Conference
June 20, 2023 07:30 ET | OpGen, Inc.
‘Multi-Center Clinical Trial Using a Novel Semi-Quantitative Multiplex-PCR Based Diagnostic Panel for Urinary Tract Specimens’ presented on June 17th, 2023Presentation focused on primary study...
OpGen.jpg
OpGen Reports First Quarter 2023 Financial Results and Provides Business Update
May 15, 2023 16:15 ET | OpGen, Inc.
Total revenue for the first quarter of 2023 was approximately $0.91 million, an increase of approximately 94% compared to the first quarter of 2022Expanded U.S. growth opportunities with the Unyvero...
OpGen.jpg
OpGen Enters Into Distribution Agreement for Unyvero in the U.S. with Fisher Healthcare
April 18, 2023 16:30 ET | OpGen, Inc.
Fisher Healthcare, a part of Thermo Fisher Scientific, will become the non-exclusive national laboratory distribution partner alongside OpGen, Inc.’s direct sales in the U.S. for the Unyvero A50...
OpGen.jpg
OpGen Submits De Novo request to the U.S. FDA for Unyvero Urinary Tract Infection Panel
April 18, 2023 07:30 ET | OpGen, Inc.
Based on large multi-center study with over 1,800 patient samplesPrimary endpoint for Unyvero UTI for urinary tract infection was successfully met and shows overall weighted average sensitivity of...
4 Pack
eMed launches first-of-its-kind eMed® Urgent Care Telehealth Kit™, enabling access to same-day clinical evaluations and prescription medications for four common illnesses
March 03, 2023 11:09 ET | eMed
MIAMI, March 03, 2023 (GLOBE NEWSWIRE) -- eMed, the leader in at-home, test-to-treat telehealth kits, today announced the first-of-its-kind eMed® Urgent Care Telehealth Kit™. Powered by eMed's...